发明名称 |
TUMOR SPECIFIC T-CELL RECEPTORS |
摘要 |
<p>The present invention relates to a method for the production of novel T-cell receptors (TCR) which provide a reduced risk of adverse events in immune therapy, specifically in adoptive T cell transfer. The TCRs produced according to the method of the invention are specific for tumor cells and do not react with healthy tissue. Furthermore provided are nucleic acids encoding the TCR of the invention, vectors and host cells comprising the TCRs of the invention as well as their use is the treatment of tumorous diseases.</p> |
申请公布号 |
CA2891967(A1) |
申请公布日期 |
2014.06.05 |
申请号 |
CA20132891967 |
申请日期 |
2013.11.29 |
申请人 |
MAX-DELBRUCK-CENTRUM FUR MOLEKULARE MEDIZIN (MDC)BERLIN-BUCH |
发明人 |
BLANKENSTEIN, THOMAS;WILLIMSKY, GERALD |
分类号 |
A61K39/00;C07K14/47;C07K14/725 |
主分类号 |
A61K39/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|